Nitroalkene Non Steroidal Anti-Inflammatory Drugs (NA-NSAIDS) and Methods of Treating Inflammation Related Conditions
Institut Pasteur de Montevideo
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,428,008 | Nitroalkene Non Steroidal Anti-Inflammatory Drugs (NA-NSAIDS) and Methods of Treating Inflammation Related Conditions In force · High confidence | Institut Pasteur de Montevideo | In force | High confidence | ||
| US 10,906,864 | Nitroalkene Non Steroidal Anti-Inflammatory Drugs (NA-NSAIDS) and Methods of Treating Inflammation Related Conditions In force · High confidence | Institut Pasteur de Montevideo | In force | High confidence | ||
| Application 17/132,238 | Nitroalkene Non Steroidal Anti-Inflammatory Drugs (NA-NSAIDS) and Methods of Treating Inflammation Related Conditions Abandoned Abandoned Mar 9, 2021 | Institut Pasteur de Montevideo | Abandoned | Abandoned Mar 9, 2021 |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Institut Pasteur de Montevideo.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.